SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for E...
IMA-203CD8 is under clinical development by Immatics and currently in Phase II f...
SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for H...
IBI-343 is under clinical development by Innovent Biologics and currently in Pha...
ILution travoprost is under clinical development by Glaukos and currently in Pha...
Anti-RANKL Monoclonal Antibody is under clinical development by Jiangsu Pacific ...
ILution travoprost is under clinical development by Glaukos and currently in Pha...
Small Molecule to Target PSMA for Metastatic Hormone Refractory Prostate Cancer ...
MEDI-0618 is under clinical development by AstraZeneca and currently in Phase I ...
DFV-890 is under clinical development by Novartis and currently in Phase II for ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...
Olanzapine ER is under clinical development by Teva Pharmaceutical Industries an...
MAS-825 is under clinical development by Novartis and currently in Phase II for ...
Olanzapine is under clinical development by Neurelis and currently in Phase I fo...
Omalizumab biosimilar is under clinical development by Teva Pharmaceutical Indus...
